Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer
Clinical trial NCT00191789 · COMPLETED
Trial details
- NCT number
- NCT00191789
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2009-04-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.